LEADER 00000cam  2200000 i 4500 
001    ocn671465409 
003    OCoLC 
005    20140411150055.0 
008    101019s2011    flua     b    001 0 eng   
010      2010044822 
016 7  101544647|2DNLM 
016 7  015600807|2Uk 
019    587104341 
020    9781439810675|q(hardcover : alkaline paper) 
020    1439810672|q(hardcover : alkaline paper) 
035    (OCoLC)671465409|z(OCoLC)587104341 
040    DNLM/DLC|beng|erda|cDLC|dYDX|dBTCTA|dYDXCP|dNLM|dCDX
       |dUKMGB|dCLU|dOCLCQ|dCHVBK|dOCLCF|dSTJ 
042    pcc 
049    STJP 
050 00 RS431.R34|bW55 2011 
060 00 2011 B-810 
060 04 WN 615|bW724r 2011 
060 10 WN 415 
082 00 615.8/424|222 
096    WN 415|bW724R 2011 
100 1  Williams, Lawrence E.,|eauthor. 
245 10 Radiopharmaceuticals :|bintroduction to drug evaluation 
       and dose estimation /|cLawrence E. Williams. 
260    Boca Raton, FL :|bCRC Press,|c©2011. 
300    xxi, 304 pages :|billustrations ;|c24 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
504    Includes bibliographical references and index. 
520    "This comprehensive overview details the process of 
       radiopharmaceutical development, from cellular studies to 
       animal experiments to the design and implementation of 
       clinical trials. It examines the relative benefits of 
       various radiopharmaceuticals and provides guidance on dose
       estimation and agent selection. Utilizing figures of merit
       for quantitative assessment, it covers standard medical 
       internal radiation dose (MIRD), absorbed dose method for 
       imaging agents, vivo methods for obtaining activity data, 
       errors of activity estimation techniques, phantom-based 
       and patient-based dose estimates and their associated 
       uncertainties, and options available to clinical 
       physicists. Supported by numerous examples from clinical 
       trials, it discusses two and three dimensional estimation 
       processes, including modern hybrid scanners such as SPECT 
       /CT and PET/CT"--Provided by publisher. 
598    STJONEW 
650  0 Radiopharmaceuticals. 
650 12 Radiopharmaceuticals. 
650 22 Clinical Trials as Topic. 
650 22 Radiopharmaceuticals|xadministration & dosage. 
938    Baker and Taylor|bBTCP|nBK0008858783 
938    YBP Library Services|bYANK|n3312754 
938    Coutts Information Services|bCOUT|n12709774 
994    01|bSTJ